Marshall Wace, LLP Tandem Diabetes Care Inc Transaction History

Marshall Wace, LLP

  • $63.3 Billion
  • Q1 2024

A detailed history of Marshall Wace, LLP transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Marshall Wace, LLP holds 3,120,374 shares of TNDM stock, worth $126 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
3,120,374
Previous 351,915 786.68%
Holding current value
$126 Million
Previous $10.4 Million 961.5%
% of portfolio
0.17%
Previous 0.02%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$22.09 - $35.41 $61.2 Million - $98 Million
2,768,459 Added 786.68%
3,120,374 $110 Million
Q4 2023

Feb 14, 2024
BUY
$14.28 - $31.03 $2.47 Million - $5.36 Million
172,875 Added 96.56%
351,915 $10.4 Million
Q3 2023

Nov 14, 2023
SELL
$19.33 - $36.22 $9.24 Million - $17.3 Million
-478,121 Reduced 72.76%
179,040 $3.72 Million
Q2 2023

Aug 14, 2023
BUY
$24.18 - $42.46 $15.9 Million - $27.9 Million
657,161 New
657,161 $16.1 Million
Q4 2022

Feb 14, 2023
BUY
$35.49 - $56.15 $31.3 Million - $49.5 Million
881,307 New
881,307 $39.6 Million
Q2 2022

Aug 15, 2022
SELL
$53.22 - $123.09 $1.31 Million - $3.04 Million
-24,703 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$101.89 - $150.09 $5.67 Million - $8.36 Million
-55,673 Reduced 69.27%
24,703 $2.87 Million
Q4 2021

Feb 14, 2022
BUY
$118.18 - $153.21 $7.63 Million - $9.89 Million
64,572 Added 408.58%
80,376 $12.1 Million
Q3 2021

Nov 15, 2021
BUY
$93.51 - $129.4 $1.48 Million - $2.05 Million
15,804 New
15,804 $1.89 Million
Q2 2021

Aug 13, 2021
SELL
$77.0 - $100.19 $369,215 - $480,411
-4,795 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$81.28 - $104.34 $52,506 - $67,403
646 Added 15.57%
4,795 $424,000
Q4 2020

Feb 16, 2021
SELL
$86.4 - $121.75 $793,497 - $1.12 Million
-9,184 Reduced 68.88%
4,149 $397,000
Q3 2020

Nov 16, 2020
BUY
$95.43 - $116.09 $328,565 - $399,697
3,443 Added 34.81%
13,333 $1.51 Million
Q2 2020

Aug 13, 2020
BUY
$60.05 - $98.92 $593,894 - $978,318
9,890 New
9,890 $978,000
Q1 2020

May 15, 2020
SELL
$47.37 - $90.04 $243,481 - $462,805
-5,140 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$53.13 - $71.19 $182,395 - $244,395
-3,433 Reduced 40.04%
5,140 $306,000
Q3 2019

Nov 14, 2019
BUY
$57.11 - $73.3 $162,135 - $208,098
2,839 Added 49.51%
8,573 $506,000
Q2 2019

Aug 14, 2019
BUY
$54.41 - $71.7 $311,986 - $411,127
5,734 New
5,734 $370,000
Q1 2019

May 14, 2019
SELL
$32.25 - $73.56 $474,042 - $1.08 Million
-14,699 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$28.45 - $40.65 $418,186 - $597,514
14,699 New
14,699 $558,000

Others Institutions Holding TNDM

# of Institutions
312
Shares Held
73.1M
Call Options Held
3.25M
Put Options Held
250K
View Full List

About TANDEM DIABETES CARE INC

TNDM Quotes by TradingView
  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $2.59B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email